Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Cardiac devices and equipment
Pacemaker CE mark with options for magnetic resonance imaging (MRI)
Cardiac devices and equipment : 26 October, 2014
Boston Scientific Corporation has received CE Mark approval for the Accolade pacemaker family. When implanted with the company's Ingevity leads, Accolade pacemakers enable patients to receive full-body MRI scans in both 1.5 Tesla and 3.0 Tesla systems. In addition, the Boston Scientific ImageReady technology offers flexible MRI option, allowing higher energy scan sequences, featuring a programmable MRI timer designed to improve patient workflow.
 
Repositionable transcatheter aortic valve system gains CE Mark
Cardiac devices and equipment : 10 January, 2014
Larger sized 29mm transcatheter aortic valve system with transfemoral delivery system gains CE mark for use in Europe
 
HeartWare receives FDA approval to enroll supplemental patient cohort in destination therapy trial
Cardiac devices and equipment : 29 August, 2013
The US Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare International to commence enrollment in an additional patient cohort for ENDURANCE, the company's pivotal, Destination Therapy clinical study.
 
Covidien opens USD21m R&D and training & education centre in South Korea
Cardiac devices and equipment : 28 August, 2013
Covidien is opening the Covidien Center of Innovation Korea (CCI Korea), which is the company's first research and development and training & education centre in Korea.
 
Man with SynCardia Total Artificial Heart surpasses two years of support
Cardiac devices and equipment : 16 August, 2013
36-year-old Frenchman Frederic Thiollet, surpasses two years of support with the SynCardia temporary Total Artificial Heart and says he is enjoying each and every day.
 
World's first Cloud-based wireless ECG receives CE certification
Cardiac devices and equipment : 12 August, 2013
WEB Biotechnology, which makes the world's first cloud-based continuous ECG monitor called the Spyder, is receiving CE certification for the company's ECG monitoring solution.
 
Cook finalises patient enrollment for study to treat arterial occlusions from the retrograde tibiopedal approach
Cardiac devices and equipment : 09 August, 2013
Cook Medical completes patient enrollment in a study evaluating a technique for achieving vascular access via below-the-knee arteries. The new access technique could be used in treating peripheral arterial disease (PAD), including patients with critical limb ischemia (CLI).
 
Medtentia Helix Ring for Mitral Valve Repair continues to achieve all objectives in approval study
Cardiac devices and equipment : 05 August, 2013
Surgeons at Helsinki University Hospital led by Prof Werkkala continue to recruit patients for the official second phase of the clinical approval study evaluating the safety and efficacy of the 'Medtentia Helix Ring in Adults Undergoing Mitral Valve Repair Surgery'.
 
Zoll CPR technology supports new AHA recommendations for improving CPR quality
Cardiac devices and equipment : 19 July, 2013
Zoll Medical's CPR technologies and data products are aiming to help organizations meet the American Heart Association (AHA) consensus statement recommending an increased focus on improving CPR quality during resuscitation from sudden cardiac arrest (SCA).
 
Zoll acquires the assets of Lifebridge Medizintechnik
Cardiac devices and equipment : 17 July, 2013
Zoll Medical purchases the assets of Lifebridge Medizintechni, based in Ampfing, Germany.
 
Sorin signs supply agreement for Boston Scientific's Lotus valve system
Cardiac devices and equipment : 16 July, 2013
Sorin signs a supply agreement for the manufacturing of certain components of the Lotus Aortic Valve System, Boston Scientific's second-generation TAVR (Transcatheter Aortic Valve Replacement) technology.
 
Welch Allyn unveils two connectivity-ready electrocardiograph devices in the USA
Cardiac devices and equipment : 16 July, 2013
Welch Allyn is introducing two connectivity-ready electrocardiograph devices in the USA.
 
GPS-like technology for CPR is shown to double survival from cardiac arrest
Cardiac devices and equipment : 28 June, 2013
ZOLL Medical Corporation, reports that survival from one of the leading causes of death in the USA, out-of-hospital cardiac arrest, more than doubled from 26 to 56 percent when paramedics in Mesa, Arizona utilised ZOLL's CPR feedback technology in combination with scenario-based training.
 
Multicentre European study to evaluate treatment system for Persistent Atrial Fibrillation
Cardiac devices and equipment : 27 June, 2013
CardioFocus' HeartLight technology becomes the focus of a multicentre European clinical study for the treatment of drug-refractory persistent AF.
 
St Jude Medical gains CE Mark approval of multipoint pacing CRT-D
Cardiac devices and equipment : 25 June, 2013
St Jude Medical receives CE Mark approval of its next-generation quadripolar device, the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D).
 
First US implant of CRT-D system is implemented for RESPOND CRT IDE clinical trial
Cardiac devices and equipment : 24 June, 2013
Sorin Group announces the first US implant of the company's PARADYM SonR CRT System for the RESPOND CRT IDE Clinical Trial.
 
HeartWare receives conditional approval from FDA to enroll supplemental patient cohort in destination therapy trial
Cardiac devices and equipment : 19 June, 2013
The US Food and Drug Administration (FDA) grants conditional approval to an IDE (Investigational Device Exemption) Supplement that allows HeartWare to commence enrollment in an additional patient cohort for ENDURANCE, the company's pivotal, Destination Therapy clinical study.
 
Study shows Covidien embolization device offers safe and effective treatment of large aneurysms
Cardiac devices and equipment : 18 June, 2013
Covidien reports that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of the company's Pipeline embolization device have been published in the June issue of Radiology (Ref 1) which is the official peer-reviewed medical journal of the Radiological Society of North America.
 
St Jude Medical receives FDA approval of high-voltage devices with added safety features
Cardiac devices and equipment : 12 June, 2013
St Jude Medical receives US Food and Drug Administration (FDA) approval of its next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
 
CardioNet enters into National Provider Agreement with UnitedHealthcare Insurance
Cardiac devices and equipment : 11 June, 2013
CardioNet has entered into a three-year National Provider Agreement with UnitedHealthcare Insurance Company, covering all of CardioNet's monitoring modalities, including Mobile Cardiac Outpatient Telemetry (MCOT).
 
Non-invasive cardiac support pump shows circulation benefits after SCA
Cardiac devices and equipment : 07 June, 2013
A paper published in Critical Care Medicine reports the likelihood of achieving a return of spontaneous circulation (ROSC) after sudden cardiac arrest (SCA) is 62 percent greater when ZOLL Medical's AutoPulse Non-invasive Cardiac Support Pump is used to deliver CPR chest compressions.
 
Biventricular pacing reduces symptoms in AV block patients with heart failure
Cardiac devices and equipment : 14 May, 2013
Medtronic reveals new data demonstrating that simultaneously pacing the lower chambers of the heart, or biventricular (BiV) pacing with a cardiac resynchronization therapy (CRT) device, improves heart failure symptoms and quality of life in a subset of heart failure patients.
 
St Jude Medical receives CE Mark approval of next-generation implantable defibrillators
Cardiac devices and equipment : 10 May, 2013
St Jude Medical receives CE Mark approval of the company's next-generation Ellipse and SJM Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
 
Biotronik's Ilesto 7 ICD/CRT-D series receives US FDA approval
Cardiac devices and equipment : 09 May, 2013
The Food and Drug Administration (FDA) grants approval for Biotronik's Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D) series.
 
Medtronic receives FDA approval of next-generation CRT-D and ICD devices
Cardiac devices and equipment : 08 May, 2013
Medtronic receives US Food and Drug Administration (FDA) approval for the company's newest cardiac devices: the Viva portfolio of cardiac resynchronization therapy with defibrillation (CRT-D) devices, and the Evera portfolio of implantable cardioverter-defibrillators (ICD).
 
Atrium Medical reveals 1-year results of the INFUSE-AMI trial
Cardiac devices and equipment : 07 May, 2013
Atrium Medical, a business unit of MAQUET Cardiovascular, reveals the 1-year results of the INFUSE-AMI (Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
 
eCardio launches dual-modality remote cardiac monitor with built-in symptom and activity capture
Cardiac devices and equipment : 02 May, 2013
eCardio Diagnostics is launching eCardio Verite - a patient-friendly, wireless monitor offering seamless transition between mobile cardiac telemetry and cardiac event monitoring when directed by a physician.
 
Boston Scientific acquires Fixate tissue band for spinal cord stimulator leads and pain pump catheters
Cardiac devices and equipment : 17 April, 2013
Boston Scientific acquires the fiXate Tissue Band and is launching the product in the USA.
 
Real-time navigation system for cardiac resynchronization therapy is released in North America
Cardiac devices and equipment : 12 April, 2013
Medtronic is releasing the CardioGuide Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and defibrillators (CRT-P and CRT-D), in the United States and Canada.
 
Terumo Cardiovascular Systems enters multi-year oximetry distribution agreement with Nonin Medical
Cardiac devices and equipment : 08 April, 2013
Terumo Cardiovascular Systems is entering into a multi-year distribution agreement with Nonin Medical, a leader in noninvasive medical monitoring.
 
Abiomed enrolls first patient in percutaneous heart pump study
Cardiac devices and equipment : 02 April, 2013
Abiomed enrolls the first patient in RECOVER RIGHT, an Investigational Device Exemption (IDE) study of Impella RP (Right Peripheral).
 
Sorin gains conditional FDA approval to conduct clinical trial using heart failure management technology
Cardiac devices and equipment : 22 March, 2013
Sorin Group receives US Food and Drug Administration (FDA) conditional approval for the company's Investigational Device Exemption (IDE) application and clinical trial protocol for RESPOND CRT.
 
ROX Medical enrolls first UK patients in hypertension trial at Eastbourne General Hospital
Cardiac devices and equipment : 20 March, 2013
ROX Medical begins enrollment of the first UK patients in the CONTROL-HTN international randomized controlled trial of the ROX FLOW procedure for the treatment of resistant hypertension (high blood pressure).
 
Boston Scientific Watchman device demonstrates positive clinical outcomes for AF patients
Cardiac devices and equipment : 12 March, 2013
Boston Scientific is reporting preliminary data in the PREVAIL clinical trial meets two out of three co-primary endpoints.
 
Survival from out-of-hospital cardiac arrest more than doubles with ZOLL CPR feedback technology
Cardiac devices and equipment : 04 March, 2013
ZOLL Medical is reporting that a publication released in the Annals of Emergency Medicine indicates that survival from one of the leading causes of death in the United States, out-of-hospital cardiac arrest (OHCA), more than doubled when emergency medical providers utilised ZOLL defibrillators as part of a focused effort to improve pre-hospital CPR quality and maximise survival from OHCA in Arizona.
 
US FDA grants approval to first single-lead ICD with atrial sensing
Cardiac devices and equipment : 26 February, 2013
The US Food and Drug Administration (FDA) is granted final approval for the Biotronik Lumax 740 DX System which a first-in-class implantable cardiac defibrillator (ICD) that utilises a single lead with atrial sensing capabilities.
 
RESPECT trial data for PFO closure lowers the patient risk of having another stroke
Cardiac devices and equipment : 12 February, 2013
St Jude Medical presents additional data from the company's landmark RESPECT trial at the American Stroke Association's International Stroke Conference 2013 in Honolulu.
 
St Jude Medical enrolls first patient in renal denervation study
Cardiac devices and equipment : 01 February, 2013
St Jude Medical is enrolling the first patient in the EnligHTN II trial which is a post-market clinical study that will further evaluate the safety and efficacy of the EnligHTN Renal Denervation System in patients with uncontrolled hypertension.
 
Defibrillator manufacturer pledges to make patient data available to reduce preventable deaths
Cardiac devices and equipment : 30 January, 2013
ZOLL Medical becomes the first major defibrillator manufacturer to publicly pledge the sharing of patient data to reduce preventable deaths.
 
St Jude Medical receives CE Mark approval of left atrial appendage occluder.
Cardiac devices and equipment : 21 January, 2013
St Jude Medical receives CE Mark approval of the company's AMPLATZER Amulet Left Atrial Appendage Occluder.
 
St Jude Medical enrolls first patient in study to develop guidance for stent optimization
Cardiac devices and equipment : 19 December, 2012
St Jude Medical is reporting the first patient enrollment in the company's ILUMIEN I clinical study.
 
Revascularization device receives regulatory approval in Canada
Cardiac devices and equipment : 14 December, 2012
Covidien's Solitaire FR Revascularization Device, is used to restore blood flow to the brain in patients suffering from acute ischemic stroke, is approved by Health Canada.
 
ZOLL releases the first paediatric electrodes that report CPR quality
Cardiac devices and equipment : 13 December, 2012
ZOLL Medical is claiming that the company's new FDA-cleared OneStep Pediatric CPR Electrodes are the only electrodes on the market with a built-in sensor that reports CPR quality on young children up to eight years of age.
 
FDA 515i panel recommends Class III status for Abiomed's temporary ventricular support devices
Cardiac devices and equipment : 10 December, 2012
The US Food and Drug Administration's (FDA) Circulatory System Devices Panel votes to retain Class III status for the temporary ventricular support devices within the non-roller type cardiopulmonary bypass blood pumps category, which includes Abiomed's Impella.
 
Sorin Group achieves first PARADYM RF implant in North America
Cardiac devices and equipment : 07 December, 2012
Sorin Group reports the first implant of PARADYM RF in Canada at the Montreal Heart Institute.
 
Sorin Group receives Japanese PMDA approval of aortic pericardial heart valve
Cardiac devices and equipment : 06 December, 2012
Sorin Group receives the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) approval for the company's Mitroflow Aortic Pericardial Heart Valve.
 
St Jude Medical receives CE Mark approval of implantable ICDs and CRT-Ds
Cardiac devices and equipment : 29 November, 2012
St Jude Medical receives European CE Mark approval of the Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
 
Boston Scientific defibrillators receive CE Mark for extended longevity
Cardiac devices and equipment : 22 November, 2012
Boston Scientific receives CE Mark approval for increased longevity projections for the INCEPTA, ENERGEN, PUNCTUA, COGNIS and TELIGEN implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
 
Sparton acquires Onyx
Cardiac devices and equipment : 22 November, 2012
Sparton, a premier supplier of electromechanical devices, sub-assemblies and related services for highly regulated environments in the Medical, military, aerospace and industrial markets announces that its wholly owned subsidiary, Sparton Onyx completed its acquisition of Onyx EMS on November 15, 2012 in a $43.25 million all-cash transaction, subject to certain post-closing adjustments.
 
Improved device programming reduces inappropriate therapy for implantable defibrillator patients
Cardiac devices and equipment : 08 November, 2012
Boston Scientific and the University of Rochester Medical Center are presenting positive results from the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) clinical trial that demonstrated improved programming of the Boston Scientific dual-chamber implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) heart devices can reduce inappropriate therapy and risk of death.
 
First | Prev  | 1 | 2 | 3 | 4 | 5 | 6  | Next  | Last
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo